In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Beamr Imaging Ltd (NASDAQ: BMR) closed the day trading at $5.52 down -4.83% from the previous closing price of $5.80. In other words, the price has decreased by -$4.83 from its previous closing price. On the day, 0.52 million shares were traded. BMR stock price reached its highest trading level at $5.94 during the session, while it also had its lowest trading level at $5.5.
Ratios:
For a better understanding of BMR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.70 and its Current Ratio is at 6.70. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.02.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BMR now has a Market Capitalization of 83381256 and an Enterprise Value of 66427412. For the stock, the TTM Price-to-Sale (P/S) ratio is 28.62 while its Price-to-Book (P/B) ratio in mrq is 7.02. Its current Enterprise Value per Revenue stands at 22.835 whereas that against EBITDA is -77.966.
Stock Price History:
Over the past 52 weeks, BMR has reached a high of $34.94, while it has fallen to a 52-week low of $0.91. The 50-Day Moving Average of the stock is -24.12%, while the 200-Day Moving Average is calculated to be 78.47%.
Shares Statistics:
Over the past 3-months, BMR traded about 5.94M shares per day on average, while over the past 10 days, BMR traded about 3440650 shares per day. A total of 13.05M shares are outstanding, with a floating share count of 8.80M. Insiders hold about 41.68% of the company’s shares, while institutions hold 0.61% stake in the company. Shares short for BMR as of 1711584000 were 625458 with a Short Ratio of 0.11, compared to 1709164800 on 389516. Therefore, it implies a Short% of Shares Outstanding of 625458 and a Short% of Float of 5.48.
Earnings Estimates
Its stock is currently analyzed by Bristol-Myers Squibb Company different market analysts. The consensus estimate for the next quarter is $108.58, with high estimates of $88.63 and low estimates of $32.60.
